Synthesis of a cytochrome c derivative with prolonged in vivo half-life and determination of ascorbyl radicals in the circulation of the rat.
Since cytochrome c and acetylated cytochrome c disappear from the circulation with a half-life of 4 min, these proteins cannot be used for in vivo detection of superoxide radicals and related metabolites. To determine superoxide and other radicals in vivo, a cytochrome c derivative (SMAC) was synthesized by linking 1 mol of poly(styrene-co-maleic acid) butyl ester (SM) to cytochrome c, followed by acetylation of its lysyl amino groups. SMAC retained 8 and 80% of cytochrome c activity to react with ascorbyl and superoxide radicals, respectively. However, SMAC did not serve as a substrate for cytochrome c reductase and cytochrome c oxidase. When injected intravenously to the rat, SMAC circulated bound to albumin with a half-life of 130 min. SMAC was rapidly reduced in the circulation of intact animals. Treatment of animals with paraquat markedly enhanced the reduction of the circulating SMAC. We have synthesized an SM-conjugated superoxide dismutase (SOD) derivative (SM-SOD) that circulates bound to albumin with a half-life of 6 h. Kinetic analysis revealed that SM-SOD effectively inhibited the superoxide-dependent reduction of SMAC either in the presence or absence of 0.5 mM albumin. However, the reduction of the circulating SMAC was not inhibited by SM-SOD both in normal and paraquat-treated animals. Plasma samples from both animal groups also reduced cytochrome c and SMAC by an SOD-insensitive mechanism. However, after treatment with ascorbate oxidase, both plasma samples lost their activity to reduce cytochrome c and SMAC. These and other results suggest that ascorbyl radical might principally be responsible for the reduction of circulating SMAC and that plasma levels of ascorbyl radical might increase in paraquat-treated animals.
Kunitomo
R
R
Department of Biochemistry, Kumamoto University Medical School, Japan.
Miyauchi
Y
Y
Inoue
M
M
D000107:Acetylation; D000818:Animals; D001204:Ascorbate Oxidase / Q000494:pharmacology; D001205:Ascorbic Acid / Q000097:blood*; D003574:Cytochrome c Group / Q000737:chemistry / Q000493:pharmacokinetics*; D004587:Electrophoresis, Agar Gel; D005609:Free Radicals; D006207:Half-Life; D008297:Male; D008298:Maleates / Q000737:chemistry / Q000493:pharmacokinetics*; D010084:Oxidation-Reduction; D010269:Paraquat / Q000494:pharmacology; D011137:Polystyrenes / Q000737:chemistry / Q000493:pharmacokinetics*; D051381:Rats; D011919:Rats, Inbred Strains; D012709:Serum Albumin / Q000378:metabolism; D013482:Superoxide Dismutase / Q000378:metabolism; D013481:Superoxides / Q000378:metabolism
D003574:Cytochrome c Group; D005609:Free Radicals; D008298:Maleates; D011137:Polystyrenes; D012709:Serum Albumin; D013481:Superoxides; C059316:poly(styrene-co-maleic acid)butyl ester; D001204:Ascorbate Oxidase; D013482:Superoxide Dismutase; D010269:Paraquat; D001205:Ascorbic Acid